Lysophosphatidic Acid Receptors LPA1 and LPA3 Promote CXCL12-Mediated Smooth Muscle Progenitor Cell Recruitment in Neointima Formation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation Research

• Publication date

  2010-07-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.109.212647PMID 20360252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy.

  2009cited by this paper
• Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.

  2009cited by this paper
• A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury

  2008cited by this paper
• Biological roles of lysophospholipid receptors revealed by genetic null mice: an update.

  2008cited by this paper
• Cancer‐Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast‐Like Cells

  2008cited by this paper
• Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular Injury Responses but Not Blood Pressure

  2008cited by this paper
• Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis

  2008cited by this paper
• Chemokines in Vascular Dysfunction and Remodeling

  2008cited by this paper
• Two-photon microscopy on vital carotid arteries: imaging the relationship between collagen and inflammatory cells in atherosclerotic plaques.

  2008cited by this paper
• Two pathways for lysophosphatidic acid production.

  2008cited by this paper
• Expression of HIF-1α in Injured Arteries Controls SDF-1α–Mediated Neointima Formation in Apolipoprotein E–Deficient Mice

  2007cited by this paper
• Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice.

  2007cited by this paper
• Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.

  2007cited by this paper
• LYSOPHOSPHATIDIC ACID REDUCES THE ORGAN INJURY CAUSED BY ENDOTOXEMIA-A ROLE FOR G-PROTEIN-COUPLED RECEPTORS AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-&ggr;

  2007cited by this paper
• Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization

  2007cited by this paper
• Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.

  2007cited by this paper
• Lysophospholipids increase IL‐8 and MCP‐1 expressions in human umbilical cord vein endothelial cells through an IL‐1‐dependent mechanism

  2006cited by this paper
• Two-Photon Microscopy of Vital Murine Elastic and Muscular Arteries

  2006cited by this paper
• Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression

  2006cited by this paper
• Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.

  2006cited by this paper
• The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

  2006cited by this paper
• SDF-1&agr;/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells

  2005cited by this paper
• Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets

  2004cited by this paper
• Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation

  2004cited by this paper
• Crucial Role of the CCL 2 / CCR 2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL 2 Presentation on Platelets

  2004cited by this paper
• Stromal Cell–Derived Factor-1 and CXCR4 Interaction Is Critical for Development of Transplant Arteriosclerosis

  2004cited by this paper
• Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Inhibit Platelet Activation Triggered by the Lipid Core of Atherosclerotic Plaques

  2003cited by this paper
• Vascular Remodeling Induced by Naturally Occurring Unsaturated Lysophosphatidic Acid In Vivo

  2003cited by this paper
• Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

  2003cited by this paper
• The emerging role of lysophosphatidic acid in cancer

  2003cited by this paper
• Crucial Role of Stromal Cell–Derived Factor-1&agr; in Neointima Formation After Vascular Injury in Apolipoprotein E–Deficient Mice

  2003cited by this paper
• Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood*

  2002cited by this paper
• Morphological Predictors of Restenosis After Coronary Stenting in Humans

  2002cited by this paper
• Transbilayer phospholipid movement and the clearance of apoptotic cells.

  2002cited by this paper
• Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis

  2002cited by this paper
• Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways*

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium.

  2001cited by this paper
• Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors.

  2001cited by this paper
• Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species

  2000cited by this paper
• Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice.

  1999cited by this paper
• Lysophosphatidic Acid Activates Nuclear Factor Kappa B and Induces Proinflammatory Gene Expression in Endothelial Cells

  1999cited by this paper
• Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

  1999cited by this paper
• The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice.

  1996cited by this paper
• Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

  1995cited by this paper
• Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta.

  1994cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.

  1991cited by this paper
• Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin.

  1989cited by this paper

• Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks

  2025cites this paper
• Hypoxia Compromises the Differentiation of Human Osteosarcoma Cells to CAR-R, a Hydroxylated Derivative of Lithocholic Acid and Potent Agonist of the Vitamin D Receptor

  2025cites this paper
• Stay or Stray: Lpar1 regulates neutrophil retention and epidermal homeostasis in early zebrafish development

  2025cites this paper
• The Autotaxin-LPA Axis Emerges as a Novel Regulator of Smooth Muscle Cell Phenotypic Modulation during Intimal Hyperplasia

  2023cites this paper
• Lipid phosphate phosphatase 3 in smooth muscle cells regulates angiotensin II-induced abdominal aortic aneurysm formation

  2022cites this paper
• Inflammatory Mediators in Atherosclerotic Vascular Remodeling

  2022cites this paper
• Exosomal Transfer of miR-185 Is Controlled by hnRNPA2B1 and Impairs Re-endothelialization After Vascular Injury

  2021influential citation
• Novel Role for Lysophosphatidic Acid in Vascular Remodeling at the Maternal-Fetal Interface.

  2020cites this paper
• REPRODUCTION Novel role for lysophosphatidic acid in vascular remodeling at the maternal–fetal interface

  2020cites this paper
• Druggable Lysophospholipid Signaling Pathways.

  2020cites this paper
• Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis.

  2020cites this paper
• Roles for lysophosphatidic acid signaling in vascular development and disease.

  2020cites this paper
• Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases

  2020influential citation
• LPA receptor 4 deficiency attenuates experimental atherosclerosis[S]

  2019influential citation
• Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.

  2019cites this paper
• Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α.

  2019cites this paper
• ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells

  2019cites this paper
• Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.

  2019cites this paper
• Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing

  2018cites this paper
• Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress

  2018influential citation
• Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages

  2017cites this paper
• The role of LPA in kidney pathologies

  2017cites this paper
• p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine–induced vascular smooth muscle cell migration and proliferation

  2017cites this paper
• Functional ex-vivo Imaging of Arterial Cellular Recruitment and Lipid Extravasation.

  2017cites this paper
• Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.

  2016cites this paper
• DNA Methylation Signature of Post-injury Neointimal Cells During Vascular Remodeling in the Rat Balloon Injury Model

  2016cites this paper
• PPAP2B EXPRESSION LIMITS LESION FORMATION IN MURINE MODELS OF ATHEROSCLEROSIS

  2016cites this paper
• Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity

  2015cites this paper
• Chemokines and microRNAs in atherosclerosis

  2015cites this paper
• Lysophospholipid mediators in the vasculature.

  2015cites this paper
• Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome

  2015cites this paper
• A method for three-dimensional quantification of vascular smooth muscle orientation: application in viable murine carotid arteries

  2015cites this paper
• Endothelial Hypoxia-Inducible Factor-1&agr; Promotes Atherosclerosis and Monocyte Recruitment by Upregulating MicroRNA-19a

  2015cites this paper
• Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.

  2014cites this paper
• Deficiency of Endothelial Cxcr4 Reduces Reendothelialization and Enhances Neointimal Hyperplasia After Vascular Injury in Atherosclerosis-Prone Mice

  2014cites this paper
• Patients with risk factors have higher plasma levels of lysophosphatidic acid: a promising surrogate marker for blood platelet activation

  2014cites this paper
• Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.

  2014cites this paper
• Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction

  2014cites this paper
• Activation of CXCR7 Limits Atherosclerosis and Improves Hyperlipidemia by Increasing Cholesterol Uptake in Adipose Tissue

  2014influential citation
• LPA receptor signaling: pharmacology, physiology, and pathophysiology

  2014cites this paper
• Lysophosphatidic Acid (LPA) Receptor Signaling

  2013cites this paper
• Regulation of the Nuclear Hormone Receptor Pparγ by Endogenous Lysophosphatidic Acids (LPAS)

  2013cites this paper
• Smooth muscle progenitor cells involved in the development of airway remodeling in a murine model of asthma.

  2013cites this paper
• Lipid Phosphate Phosphatase 3 Negatively Regulates Smooth Muscle Cell Phenotypic Modulation to Limit Intimal Hyperplasia

  2013cites this paper
• Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.

  2013cites this paper
• Nuclear Factor of Activated T Cells c1 Mediates p21-activated Kinase 1 Activation in the Modulation of Chemokine-induced Human Aortic Smooth Muscle Cell F-actin Stress Fiber Formation, Migration, and Proliferation and Injury-induced Vascular Wall Remodeling*

  2013cites this paper
• CXCL12 Promotes the Stabilization of Atherosclerotic Lesions Mediated by Smooth Muscle Progenitor Cells in Apoe-Deficient Mice

  2013cites this paper
• Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice

  2013cites this paper
• Lysophospholipid variants in hepatocellular carcinoma.

  2013cites this paper
• Regulation of angiogenesis and bone regeneration with natural and synthetic small molecules.

  2013cites this paper
• The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis

  2013cites this paper
• Lysophosphatidic Acid (LPA) Signaling and Cardiovascular Pathology

  2013cites this paper
• Injury‐Activated Transforming Growth Factor β Controls Mobilization of Mesenchymal Stem Cells for Tissue Remodeling

  2012cites this paper
• The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation

  2012cites this paper
• β-Hairpin protein epitope mimetic technology in drug discovery.

  2012cites this paper
• Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.

  2012cites this paper
• Smooth Muscle Progenitor Cells

  2012cites this paper
• Lysophosphatidic acid : role in CXCL12-mediated vascular repair and atherogenic monocyte recruitment

  2012cites this paper
• Circulation Research Thematic Synopsis: Atherosclerosis

  2012cites this paper
• TISSUE-SPECIFIC STEM CELLS Injury-Activated Transforming Growth Factor b Controls Mobilization of Mesenchymal Stem Cells for Tissue Remodeling

  2012cites this paper
• Lysophosphatidic acid in atherosclerotic diseases

  2012influential citation
• OPINION Atherosclerosis: cell biology and lipoproteins – New mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells

  2012cites this paper
• Protein Kinase N1 Is a Novel Substrate of NFATc1-mediated Cyclin D1-CDK6 Activity and Modulates Vascular Smooth Muscle Cell Division and Migration Leading to Inward Blood Vessel Wall Remodeling*

  2012cites this paper
• Plasticity-related gene-1 inhibits lysophosphatidic acid-induced vascular smooth muscle cell migration and proliferation and prevents neointima formation.

  2012cites this paper
• US28 Is a Potent Activator of Phospholipase C during HCMV Infection of Clinically Relevant Target Cells

  2012influential citation
• Circulation Research Thematic Synopsis Atherosclerosis

  2012cites this paper
• Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

  2011cites this paper
• Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium.

  2011influential citation
• Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells*

  2011cites this paper
• Lysophosphatidic acid-1-receptor targeting agents for fibrosis

  2011cites this paper
• Lysophosphatidic acid effects on atherosclerosis and thrombosis.

  2011cites this paper
• Phenotype and differentiation of bone marrow‐derived smooth muscle progenitor cells

  2011influential citation
• Circulating smooth muscle progenitor cells in arterial remodeling.

  2011influential citation
• Lysophosphatidic acid production and signaling in platelets

  2011cites this paper
• Lysophosphatidic acid effects on atherosclerosis and thrombosis

  2011cites this paper
• The microRNA-342-5 p Fosters Inflammatory Macrophage Activation Through an Akt 1-and microRNA-155 – Dependent Pathway During Atherosclerosis

  year unknowncites this paper